- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for icgn
Why Is Ocugen (OCGN) Stock Up 5% Today?
Ocugen stock is rising higher on Tuesday thanks to OCGN investors celebrating news of a new clinical trial for its Covid-19 vaccine.
The Reasons to Avoid OCGN Stock Keep Piling Up
OCGN stock got a bump on Phase 3 results but was met with market skepticism following its subsequent strategic moves.
Why Is Ocugen (OCGN) Stock Up 10% Today?
Sometimes, improved investor sentiment and a revamped website is enough of a catalyst to take something like OCGN stock on a 10% ride higher.
OCGN Stock Alert: Why Is Ocugen Gaining Today?
Ocugen’s stock is up more than 5% after the latest clinical trial results showed its Covid-19 vaccine booster shot had positive results.
General Electric Stock Is Back to Being an American Icon
GE stock is back to being an American icon but it still has a long way back to old glory. With time, this team will…
OCGN Stock: What to Know as Ocugen Soars Today
With ink drying on its deal with Bharat Biotech, Covid-19 vaccine stock Ocugen ended the week on a strong bullish note.
OCGN Stock Falls Despite Positive FDA Update
Shares of the biotech company are falling despite news that the FDA has cleared it to resume clinical trials of its Covid-19 vaccine.
Can Pat Toomey Save Ocugen (OCGN) Stock?
Shares of OCGN stock received a boost this morning following the addition of some high-profile names to Ocugen’s advisory board.
Why Is Ocugen (OCGN) Stock Down 22% Today?
Ocugen (OCGN) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering for its shares.
Why Is Ocugen (OCGN) Stock Climbing Higher Today?
Ocugen (OCGN) stock is gaining on Tuesday after Mizuho Securities analysts initiated coverage of the medical company’s shares.
Icon (ICLR) Raised to Strong Buy from a Buy
Icon Plc (NASDAQ:ICLR) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector…
Solid Earnings Growth Keep Icon (ICLR) a Buy
Currently, Icon Plc (NASDAQ:ICLR) has a Buy using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. ICLR has maintained this…
Ringling Brothers Circus to Phase Out Iconic Elephants
The Ringling Brothers Circus, announced on Thursday, that it won’t have elephant acts by 2018 as it phases the animals out of its shows.
Icon Plc (ICLR) Stock is Cultivating a Strong Business
Icon Plc has seen strong growth since its inception in 1990, and ICLR stock is promising, if still a little risky.
Iconic Luxury Retailer Henri Bendel Closing for Good
Henri Bendel, a luxury retailer based in NYC, is closing its doors for good as owner L Brands (LB) looks to save some money.
5 Stephen Hawking Quotes to Remember the Iconic Physicist
Stephen Hawking passed away early on Wednesday morning while at his home in Cambridge and ‘InvestorPlace’ is remembering him with some quotes.
How Buffett & 6 Other Icons Fared in 2010
Who had a better year on Wall Street — Warren Buffett, Carl Icahn or Jim Cramer?
3 Iconic American Brands Destined for the Trash Heap
The economic downturn — and in some cases, just good, old-fashioned obsolescence — is taking a toll on these three American mainstays.
Why Is Landos Biopharma (LABP) Stock Up 168% Today?
Landos Biopharma stock is up on Monday as LABP investors learn about a massive acquisition deal with AbbVie that values it at $137.5 million.
Why You Should Keep Your Distance from Ocugen Stock
Off and on the price chart OCGN stock, today’s reality is bleak for shareholders, but being a bear poses its own challenges.
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!
While the contrarian bullish argument for OCGN stock has picked up considerable chatter, this is an extremely risky trade.
Entry Into Infectious Disease Field Creates Opportunity for Ocugen
Now that Ocugen is collaborating to develop a Covid-19 vaccine, OCGN stock holders should brace for a possible regulatory authorization.
8 – 10 of 240 results
